Case Report: Steroid-Refractory Immune-Mediated Colitis in a Patient With Metastatic Lung Cancer Treated With Pembrolizumab
Patient History A 63-year-old male with metastatic non-small cell lung cancer (NSCLC) was started on pembrolizumab as first-line immunotherapy. The patient had no prior history of inflammatory bowel disease or autoimmune disorders. Clinical Course...